Skip to content

Exercise Prehabilitation for Locoregional Esophageal Cancer

Exercise Prehabilitation for Locoregional Esophageal Cancer: A Pilot Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06430346
Enrollment
20
Registered
2024-05-28
Start date
2024-05-21
Completion date
2027-05-31
Last updated
2025-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal Cancer

Brief summary

The purpose of the study is to examine the feasibility and acceptability of exercise prehabilitation for patients preparing for esophageal cancer resection (removal).

Interventions

BEHAVIORALExercise

Physical activity and resistance training

Sponsors

H. Lee Moffitt Cancer Center and Research Institute
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Biopsy-proven locoregional esophageal cancer (LEC) * Eastern Cooperative Oncology Group (ECOG) performance status 0-2 * Treatment plan including neoadjuvant chemoradiation therapy and surgical resection * Ability to read and speak English

Exclusion criteria

* Regular engagement in resistance training (2x/week targeting all major muscle groups) * Screen failure for exercise safety based on PAR-Q * Underlying unstable cardiac or pulmonary disease or symptomatic cardiac disease * Recent fracture or acute musculoskeletal injury that precludes ability to participate in resistance training safely * Numeric pain rating scale of 7 or more out of 10 * Myopathic or rheumatologic disease that impacts physical function

Design outcomes

Primary

MeasureTime frameDescription
RetentionUp to 11 weeksThe number of participants who complete T0 and T1 measures.

Secondary

MeasureTime frameDescription
Exploratory outcomes and changesUp to 17 weeksThe number of participants who demonstrate improvements in exploratory outcome measures.
Clinical and treatment outcomesUp to 17 weeksChi-square testing will be used to determine if there's a difference in perioperative outcomes between groups.

Countries

United States

Contacts

Primary ContactNathan Parker, PhD
Nathan.Parker@moffitt.org813-745-6849

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026